Business · 24/03/2015
FDA Releases Guidance on Environmental Assessments for Gene Therapies and Vaccines
The FDA has made available a guidance document outlining recommendations for determining the need and content of environmental assessments for gene therapies, vectored vaccines, and related products, providing clarity for industry sponsors and applicants.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →